PROM1 and neoplasm: Thereafter, these engineered cells exerted significantly anti-tumor effects on HCC cells and xenograft mouse models, implying that employing an approach incorporating CD133 CAR-T and PD-1 scFv cells may present a viable choice for individuals dealing with advanced HCC and upregulated expression of CD133 (81).